n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
A director at Bayer AG sold 8,319,898 shares at 37.250EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
With the glyphosate litigation nearing a decision, we think investors will refocus on Bayer's fundamentals. Improved prospects in the Pharma division and multiple tailwinds in CropScience in 2027 will provide further impetus. Additionally, as litigation risks fade and the DSO programme progresses, the spin-off of Consumer Health could be back on the table. All this fundamentally alters our assessment of Bayer, and we are upgrading the stock to Outperform, with a new TP of € 55.
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: INDRA. EUROPA: BAYER, DHL GROUP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Vuelta de números verdes Las bolsas europeas rebotaron por encima del +1,5% (el Ibex cerca del +3,0%) a pesar de que la guerra en Oriente Medio siguió generando in...
Rdos. 4T'25 vs 4T'24: Ventas: 11.438 M euros (-2,5% vs -6,2% BS(e) y -3,3% consenso); EBITDA: 1.968 M euros (-16,2% vs -20,8% BS(e) y -18,7% consenso). Rdos. 2025 vs 2024: Ventas: 45.575 M euros (-2,2% vs -3,2% BS(e) y -2,4% consenso); EBITDA: 9.669 M euros (-4,5% vs -5,6% BS(e) y -5,1% consenso).
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: REPSOL EUROPA: ADIDAS, BAYER, PROSUS Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Oleada de ventas donde sólo se salvó el crudo Jornada de fuertes caídas en la mayoría de los índices mundiales (algo más contenidas en EE.UU.), con el temor a ...
Two Directors at Nufarm Limited bought 25,500 shares at between 1.550USD and 1.600USD. The significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
A director at Albemarle Corp sold 5,692 shares at 165.450USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
A director at Kerry Group bought 756 shares at 6,515p and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.